Synthesizing Human Insulin by Molly Nicholson With the Duke Institute for Genome Sciences & Policy Center for Genome Ethics, Law & Policy.

Slides:



Advertisements
Similar presentations
Commercializing Discoveries: Disclosing your Intellectual Property By Ryan N. Fiorini, Ph.D., MBA, MHA Licensing and Commercialization Manager MUSC Foundation.
Advertisements

Genetic Engineering. Vocabulary Gene – sequence of DNA that codes for a trait (protein). Genome – an organism’s complete genetic information. Transgenic.
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
A Novel Multigene Family May Encode Odorant Receptors: A Molecular Basis for Odor Recognition Linda Buck and Richard Axel Published in Cell, Volume 65,
Welcome Meeting for New Staff University Structure Updated January 2011.
BLAST Genomics Data in the Public Domain Stacy Lavin IGSP Center for Genome Ethics, Law & Policy.
Biochemistry Ch6. Exploring Gens 阮雪芬 NTUT Oct 14, 2002.
General Microbiology (Micr300) Lecture 11 Biotechnology (Text Chapters: ; )
University Investigators and Small Biotech Companies Jane Shelby, PhD Bozeman, Montana Funding and Regulatory Consultant Biotech Industry Executive Director.
HC70A Winter 2006 Genetic Engineering in Medicine, Agriculture, and Law Professor Bob Goldberg Class Announcements 2/2/06.
The Alfred E. Mann Institute for Biomedical Engineering An Experiment in Technology Transfer Gerald E. Loeb, M.D. Director of the Medical Device Development.
Thinking of Studying Biological Sciences? Dr Amrit Mudher Lecturer in Neurosciences School of Biological Sciences University of Southampton
CESG is supported by the National Institute of General Medical Sciences through the Protein Structure Initiative NIGMS grant number U54 GM
Lecture 10 Chapter 7 Recombinant DNA, Vector Design and Construction Neal Stewart.
US National Academies Committee on Women in Science, Engineering, and Medicine (CWSEM)
PANEL Presentation 4 October 2004 Dr Mark Heffernan CEO.
Biotechnology Final Project Recombinant DNA Gene Cloning.
Recombinant DNA and Cloning The Impact of Biotechnology Honors Genetics Ms. Susan Chabot Lemon Bay High School.
Experience.  Lecture “ Alive cells –drugs - from medical, pharmaceutical and ethical aspects  Stem cells became the serious of scientific research,
6.2 Genetic Engineering. Genetic Engineering Altering the sequence of DNA molecules Important in developing drugs Insulin  Human insulin produced by.
Institute of Biotechnology and Antibiotics (IBA) Presented by Małgorzata Kęsik Assistant Professor at IBA.
Genetic Engineering Do you want a footer?.
HC70A Winter 2006 Genetic Engineering in Medicine, Agriculture, and Law Professor Bob Goldberg Course Administratorp.
Stem cells and gene therapy to repair the damaged heart: will it work and is it right? John Martin Professor of Cardiovascular Medicine University College.
Biodefense Vaccines, Therapeutics and Diagnostics NGIC Workshop September 27, 2004 Robert L. McKown, Ph.D.
What Is Biotechnology? An Introduction BioScience Survey An Introduction BioScience Survey.
BASIC LABORATORY SKILLS: WHAT OUR STUDENTS NEED TO SUCCEED Bio-Link Summer Fellows, 2010 Jeanette Mowery and Lisa Seidman Madison Area Technical College.
Responsible Conduct of Research (RCR) Farida Lada October 16, 2013
Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.
SYNBIOLOGY - An Analysis of Synthetic Biology Research in Europe and North America 4,5/4,5 CM SYNBIOLOGY: An Analysis of Synthetic Biology Research in.
The influence of bipolar drugs on the phospholipid biosynthetic pathway in Saccharomyces cerevisiae This study investigates a specific yeast, Saccharomyces.
Biotechnology pp WHAT IS IT?  Biotechnology : the application of technology to better use DNA and biology.
Recombinant DNA Technology Pre-AP Biology 10/5/2015.
Objective BT11.02:Analyze transgenic animals.. Early beginnings Biotechnology – collection of scientific techniques that use living cells and molecules.
State University of New York at Stony Brook Clinton Rubin, Ph.D. Professor & Chair Department of Biomedical Engineering Forum on Innovation and Entrepreneurship.
April 2003Takuji Hara, Kobe University 1 Roles of Technology Licensing Organizations (TLOs) in the Commercialization of Life Sciences ~ Japan ’ s Situation.
Genetically Modified Organisms (GMOs) ANIMALS Ji Young Kim.
Copyright © 2010 Pearson Education Inc. Lecture 01 – Genetics & Genomics: An Introduction Based on Chapter 1 – Genetics: An introduction.
Science & Technology Centers Program Center for Science of Information National Science Foundation Science & Technology Centers Program Bryn Mawr Howard.
Tomorrow’s Big Science Requires Big Partnerships John D. Petersen President University of Tennessee American Chemical Society August 30, 2005.
Information Ethics Dr. Marti Smith, The College of Information Science and Technology, Drexel University January, 2006.
1 AAUC Board Meeting January 2012 Report. Overview Philanthropy at UC Legislative Advocacy Financial Stability and Predictability 2.
BIOMEDICAL ENGINEERING UCIrvine University of California, Irvine Andrew J. Putnam, Ph.D. Assistant Professor Workshop on BME Teaching of Innovation, Design.
HC70A Winter 2006 Genetic Engineering in Medicine, Agriculture, and Law Professor Bob Goldberg Class Announcements 2/28/06.
Summary for the Conference. Synthesize genomes of several species completely. Synthetic biology in industrial development. Bio-systems and quantitive.
Biotechnology Intro & Gel Electrophoresis Test:__________% Test:__________%
What is Biotechnology? Chapter Biotechnology Introduction For centuries humans manipulate living organisms for desired characters Increased milk,
Recombinant DNA and Cloning The Impact of Biotechnology Honors Genetics Ms. Susan Chabot Lemon Bay High School.
HC70A Winter 2006 Genetic Engineering in Medicine, Agriculture, and Law Professor Bob Goldberg Class Announcements 2/21/06.
Cloning DNA, Plasmids and Transformations By: Stephen Sullivan and Julie Ethier.
So you are thinking about changing jobs… John E. Delzell, Jr, MD, MSPH Heidi Chumley, MD Andrea Manyon, MD.
Emerging Developments in Gene Therapy and DNA Vaccines To Succeed, Gene Therapy Must Overcome Early Setbacks “Gene therapy has suffered some serious setbacks.
How did the pig on pg. 342 become ‘glowing’? How does this relate to the transformation lab?
Warmup 4/12/16: Place Unit 6 Vocabulary in folder at your station. Complete Unit 5 Key Review Questions on a separate sheet of paper. Be sure to write.
OPEN ACCESS INITIATIVE at U.S. Department of Transportation LIBRARY PERSPECTIVE 2014 TRB Annual Meeting January 16, 2014 Lisa D. Zilinski Data Services.
Fermin Morales 3/17/14. Table of Contents  What does a Biochemist do?  Requirements to become a Biochemist  Jobs in present and future  Universities.
Primary Sources and Community Engagement
Anu Kotha IGSP Center for Genome Ethics, Law & Policy
The Department of Biochemistry & Molecular Biology
Universities and the Commercial World
Recombinant DNA Technology
Promosome Corporate Introduction
RFLP “Restriction Fragment Length Polymorphism” Basic idea: Uses:
Chapter 1. The Molecular Biotechnology Revolution
RFLP “Restriction Fragment Length Polymorphism” Basic idea: Uses:
Methuselah Laboratories Inc.
University of California, San Francisco
تعلم الوالدين حزمة التعلم داخل الروضة
Immunotherapeutics 18th Annual Research Retreat
Genetic Engineering in Medicine, Professor Bob Goldberg
Presentation transcript:

Synthesizing Human Insulin by Molly Nicholson With the Duke Institute for Genome Sciences & Policy Center for Genome Ethics, Law & Policy

Agenda  The players—Harvard, UCSF, Genentech  Basic timeline  Key hurtles  Individual strategies  Outcome  Conclusions  Sources and further research

The Players  University of California San Francisco  Genentech, Inc.  Harvard Biology Laboratories  Also…Eli Lilly and Company, Biogen, Novo Industri, Nordisk

Major Milestones January 1977Cloning of rat insulin October 1977Synthesis of human somatostatin May 1978 Expression of rat insulin in bacteria August 1978Synthesis of human insulin!

Key Factors  Open sharing of data  Government regulation  Relationship with the public and media  Intellectual Property  Business and Academia

The Harvard Biology Laboratories

Harvard  Moratorium on recombinant DNA research and P-3 laboratory facility  Patents  “Protein synthesis” (1983)  “Recombinant DNA molecule” (1986)  Biogen  The Midnight Hustler

University of California San Francisco ? William Rutter Chair of the Department of Biochemistry and Biophysics Howard Goodman Associate professor of Biochemistry Medical Sciences Building

UCSF The Rutter and Goodman Labs  pBR 322  Howard Goodman  Negotiations and agreements with Eli Lilly and Genentech, Inc.  Regents of the University of California v. Eli Lilly and Company (1990) Axel Ullrich

Genentech, Inc. UCSF and City of Hope National Medical Center Bob Swanson Founder of Genentech, Inc. Herbert Boyer Co-founder of Genentech, Inc., and UCSF professor of biochemistry

Genentech, Inc.  Difficulties separating from UCSF  Herb Boyer  Active recruiting  City of Hope lawsuit

Outcome  Genentech wins!  UCSF loses:  Weak patents  Harvard loses:  Fails to clone human insulin first

Conclusions  UCSF lost because:  Weak patent management and application  Lack of open data sharing led to tense working environment  Howard Goodman  Harvard lost because:  Government regulation

Sources  Stephen Hall, Invisible Frontiers: The Race to Synthesize a Human Gene (1987)  Judge Hugh S. Dillin’s Memorandum of Opinion re. Regents of the University of California v. Eli Lilly and Company  Oral histories collected by Sally Smith Hughes at UC Berkeley Libraries

Further Research Scheduled interviews with:  Walter Gilbert (Harvard)  John Baxter (UCSF) Administrators at the patent/technology transfer offices at UCSF, Harvard and Genentech

Questions?